🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ELIGIBILITY * Non-small cell lung cancer Clinical Stage 1A (T1N0M0 a tumor...
Status
Completed
Location
Toronto General Hospital
Start Date
2005-01
Trial ID
NCT00188617
Treatments Being Tested
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
Combining nimotuzumab to gefitinib may not only potentiate cellular cytotox...
Status
Completed
Location
Severance hospital, Yonsei Cancer Center
Start Date
2011-12
Trial ID
NCT01498562
Treatments Being Tested
The safety, tolerability and recommended phase 2 dose (RP2D) of the combina...
Status
Completed
Location
National Cancer Centre Singapore
Start Date
2011-10-03
Trial ID
NCT01570296
Treatments Being Tested
This is a phase III, open label, randomized controlled multi-center global ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-07-24
Trial ID
NCT03529084
Treatments Being Tested
Fruquintinib in combination with Gefitinib as first-line therapy in patient...
Status
Completed
Location
Shanghai Chest Hospital
Start Date
2016-12
Trial ID
NCT02976116
Treatments Being Tested
Gefitinib is an orally active epidermal growth factor receptor-tyrosine kin...
Status
Unknown
Location
National Cancer Center
Start Date
2010-06
Trial ID
NCT01027676
Treatments Being Tested
This study was designed to determine the safety and tolerability of PB101 (...
Status
Completed
Location
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital
Start Date
2018-09-01
Trial ID
NCT07271446
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of gefitinib...
Status
Completed
Location
Research Site
Start Date
2012-03-15
Trial ID
NCT01544179
Treatments Being Tested
This is a single arm phase II clinical trial, which aims to evaluate the ef...
Status
Unknown
Location
Department of Oncology, Shanghai pulmonary hospital
Start Date
2016-11
Trial ID
NCT02930954
Treatments Being Tested